Targeting the human kinome: cancer drug discovery
3,928 views · Published 26 September 2014 · 1:13:08 · Indexed 26 October 2026
Channel: The Royal Society · 2014 · Science & Technology
GlaxoSmithKline Prize and Lecture by Dr Nicholas Lydon FRS, founder of Granite Biopharma LLC. Nicholas Lydon played a decisive role in the development of Gleevec (Imatinib), a drug that has saved the lives of thousands of patients with chronic myelogenous leukaemia (CML) and gastrointestinal stromal tumours (GIST). In this prize lecture he discusses how the discovery of the Philadelphia chromosome provided the first example of a link between cancer and a recurrent genetic abnormality. The Royal Society GlaxoSmithKline Prize and Lecture is awarded biennially for original contributions to medical and veterinary sciences. Read more about 2014's prize here: https://royalsociety.org/events/2014/09/GlaxoSmithKline-Lecture/ 6:30 pm — 7:30 pm on Tuesday 23 September 2014 at The Royal Society, London.
More from this channel
-
1:02
Professor Tim Palmer on climate change
-
0:19
Marine life viewed from a remotely operated vehicle
-
4:49
Biofuels
-
4:57
Royal Society Enterprise Fund
-
5:56
Royal Society Support for Innovation 2008-9
-
4:39
Aventis Prize for Science Books 2006 - the Junior Prize shortlist
-
4:34
Aventis Prize 2006 General Prize shortlist 2006
-
1:29
Aventis Prizes for Science Books 2006 - introduction to the Junior Prize